BIOA

BioAge Labs (BIOA)

About BioAge Labs (BIOA)

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

Details

Daily high

$12.74

Daily low

$12.00

Price at open

$12.29

52 Week High

$13.10

52 Week Low

$2.88

Market cap

448.5M

Dividend yield

0.00%

Volume

224,119

Avg. volume

444,381

P/E ratio

-5.92

BioAge Labs News